MedPath

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients

Active, not recruiting
Conditions
Recurrent Pericarditis
First Posted Date
2020-12-29
Last Posted Date
2025-04-29
Lead Sponsor
Kiniksa Pharmaceuticals International, plc
Target Recruit Count
500
Registration Number
NCT04687358
Locations
🇺🇸

Houston Methodist Hospital, Houston, Texas, United States

🇺🇸

Alaska Heart & Vascular Institute, Anchorage, Alaska, United States

🇺🇸

Pima Heart and Vascular, Tucson, Arizona, United States

and more 26 locations

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Phase 2
Completed
Conditions
COVID
Interventions
Other: Placebo
First Posted Date
2020-06-25
Last Posted Date
2025-01-22
Lead Sponsor
Kiniksa Pharmaceuticals International, plc
Target Recruit Count
814
Registration Number
NCT04447469
Locations
🇵🇪

Hospital Nacional Cayetano Heredia, San Martín De Porres, Peru

🇧🇷

Hospital Cardio Pulmonar, Salvador, Bahia, Brazil

🇺🇸

UCLA Medical Center, Los Angeles, California, United States

and more 29 locations
© Copyright 2025. All Rights Reserved by MedPath